In addition, a study using serum samples from CHIKV-infected humans in Malaysia demonstrated that B cells produce neutralizing IgM antibodies targeting CHIKV surface glycoproteins E1 and E2 at day 6 post-infection, and the production of these antibodies is associated with lower levels of viremia [272]. Here, CD40LG is linked to infection.